{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:40:30Z","timestamp":1780555230485,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.pupt.2003.08.004","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"27-34","source":"Crossref","is-referenced-by-count":67,"title":["Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)"],"prefix":"10.1016","volume":"17","author":[{"given":"Mario","family":"Malerba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ponticiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Radaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Bensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2003.08.004_BIB1","series-title":"Synopis for clinical pulmonary disease","first-page":"146","article-title":"Chronic obstructive pulmonary disease","author":"Mitchell","year":"1989"},{"key":"10.1016\/j.pupt.2003.08.004_BIB2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM196806202782501","article-title":"Site and nature of airway obstruction in chronic obstructive lung disease","volume":"278","author":"Hogg","year":"1968","journal-title":"N Eng J Med"},{"key":"10.1016\/j.pupt.2003.08.004_BIB3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/0470868678.ch5","article-title":"Mucus hypersecretion in chronic obstructive pulmonary disease","volume":"234","author":"Rogers","year":"2001","journal-title":"Novartis Found Symp"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2003.08.004_BIB4","first-page":"195","article-title":"Drug effects on visco-elasticity of mucus","volume":"61","author":"Puchelle","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.pupt.2003.08.004_BIB5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000195871","article-title":"Long-lasting effects on rheology and clearance of bronchial mucus after short-term administartion of high doses of carbocysteine-lysine to patients with chronic bronchitis","volume":"57","author":"Braga","year":"1990","journal-title":"Respiration"},{"issue":"Suppl. 111","key":"10.1016\/j.pupt.2003.08.004_BIB6","first-page":"93","article-title":"Long term oral acetylcysteine in chronic bronchitis. A double blind controlled study","volume":"61","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.pupt.2003.08.004_BIB7","first-page":"405","article-title":"Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organised by the Swedish Society for Pulmonary Diseases","volume":"64","author":"Boman","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.pupt.2003.08.004_BIB8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00606554","article-title":"A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis","volume":"9","author":"Grassi","year":"1976","journal-title":"Eur J Clin Pharm"},{"key":"10.1016\/j.pupt.2003.08.004_BIB9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0954-6111(05)80337-3","article-title":"Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis","volume":"88","author":"Hansen","year":"1994","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.pupt.2003.08.004_BIB10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/030006058401200312","article-title":"Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study","volume":"12","author":"Jackson","year":"1984","journal-title":"J Int Med Res"},{"issue":"11","key":"10.1016\/j.pupt.2003.08.004_BIB11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/thx.40.11.832","article-title":"Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction","volume":"40","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2003.08.004_BIB12","first-page":"18","article-title":"Langzeittherapie mit Acetykcystein Retard-Tabletten bei Patienten mit chronischer bronchitis. Eine doppel-blinde-placebokontrollierte studie","volume":"25","author":"Meister","year":"1986","journal-title":"Forum Prakt Allg Arzt"},{"key":"10.1016\/j.pupt.2003.08.004_BIB13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0007-0971(87)90182-3","article-title":"Oral fabrol (oral N-acetyl-cysteune) in chronic bronchitis","volume":"81","author":"Parr","year":"1987","journal-title":"Br J Chest Dis"},{"key":"10.1016\/j.pupt.2003.08.004_BIB14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000029447","article-title":"N-acetylcisteine reduces the exacerbation rate in patients with moderate to severe COPD","volume":"66","author":"Pela","year":"1999","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2003.08.004_BIB15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.93.01040351","article-title":"Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis","volume":"1","author":"Rasmussen","year":"1988","journal-title":"Eur Respir J"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2003.08.004_BIB16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000195274","article-title":"Ambroxol for the prevention of chronic bronchitis exacerabations: long-term multicentre trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo","volume":"51","author":"Olivieri","year":"1987","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2003.08.004_BIB17","first-page":"618","article-title":"A controlled trial of ambroxol in chronic bronchitis","volume":"4","author":"Guyatt","year":"1992","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pupt.2003.08.004_BIB18","first-page":"715","article-title":"Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients","volume":"42","author":"Cegla","year":"1988","journal-title":"Prax Klin Pneumol"},{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2003.08.004_BIB19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000195272","article-title":"Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function","volume":"51","author":"Ericsson","year":"1987","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2003.08.004_BIB20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000196540","article-title":"Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteyne lysine salt monohydrate: a multicener, double blind, placebo controlled trial","volume":"63","author":"Allegra","year":"1996","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.pupt.2003.08.004_BIB21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The National Mucolytic Study. Results of a randomized, double-blind, placebo controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"Petty","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2003.08.004_BIB22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1378\/chest.109.2.348","article-title":"Iodinate glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis","volume":"109","author":"Rubin","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2003.08.004_BIB23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.322.7297.1271","article-title":"Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: a systematic review","volume":"322","author":"Poole","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2003.08.004_BIB24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.pupt.2003.08.004_BIB25","first-page":"798","volume":"46","author":"Pauwels","year":"2001","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2003.08.004_BIB26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1378\/chest.80.6.881","article-title":"Effects of a beta-adrenegic drug and secretolytic agent on regional mucociliary clearance in patients with, COLD","volume":"80","author":"Weiss","year":"1981","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2003.08.004_BIB27","first-page":"142","article-title":"Improvement of mucociliary transport in smokers by mucolytics","volume":"66","author":"Olivieri","year":"1985","journal-title":"Eur J Respir Dis"},{"key":"10.1016\/j.pupt.2003.08.004_BIB28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02713884","article-title":"The perfused rat lung as a model for studies on the formation of surfactant and the effect of ambroxol on this process","volume":"161","author":"Post","year":"1983","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2003.08.004_BIB29","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2003.08.004_BIB30","series-title":"SAS\/STAT user's guide. Version 6","year":"1989"},{"issue":"2","key":"10.1016\/j.pupt.2003.08.004_BIB31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcsteine in chronic bronchopulmonary disease: a metha-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.pupt.2003.08.004_BIB32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis, a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2003.08.004_BIB33","series-title":"Pulmonary surfactant","first-page":"203","article-title":"Surfatant\u2013mucus interaction","author":"Rensch","year":"1984"},{"key":"10.1016\/j.pupt.2003.08.004_BIB34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02713827","article-title":"Lung surfactant and pulmonary toxicytology","volume":"163","author":"Haagsman","year":"1985","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2003.08.004_BIB35","series-title":"Pulmonary surfactant","first-page":"188","article-title":"Role of surfactant in the pulmonary defence system","author":"Jarstrand","year":"1984"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553903001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553903001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:49:33Z","timestamp":1704973773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553903001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1094553903001111"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2003.08.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}